Gestational age-dependent extravillous cytotrophoblast osteopontin immunolocalization differentiates between normal and preeclamptic pregnancies

American Journal of Reproductive Immunology

Volumn 40, Issue 5, 1998, Pages 339-346

  Gabinskaya, Tatyana ^a   Salafia, Carolyn M ^b   Gulle, Veronica E ^a   Holzman, Ian R ^a   Weintraub, Andrea S ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b MONTEFIORE MEDICAL CENTER   (United States)

Author keywords

Extracellular matrix; Invasion; Vascular smooth muscle

Indexed keywords

OSTEOPONTIN;

ARTICLE; CONTROLLED STUDY; CYTOTROPHOBLAST; EXTRACELLULAR MATRIX; FEMALE; FETUS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INTRAUTERINE GROWTH RETARDATION; PLACENTA VILLUS; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; PROTEIN LOCALIZATION;

EID: 0031796230     PISSN: 10467408     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0897.1998.tb00063.x     Document Type: Article

References (34)

1. Zhou Y, Damsky CH, Chiu K, Roberts JM, Fisher SJ: Preeclampsia is associated with abnormal expression of adhesion molecules by invasive cytotrophoblasts. J Clin Invest 1993; 91:950-960.
2. Zhou Y, Fisher SJ, Janatpour M, Genbacev O, Dejana E, Wheelock M, Damsky CH: Human cytotrophoblasts adopt a vascular phenotype as they differentiate: A strategy for successful endovascular invasion? J Clin Invest 1997; 99:2139-2151.
3. Damsky CH, Fitzgerald ML, Fisher SJ: Distribution patterns of extracellular matrix components and adhesion receptors are intricately modulated during first trimester cytotrophoblast differentiation along the invasive pathway, in vivo. J Clin Invest 1992; 89:210-222.
4. Genbacev O, Joslin R, Damsky CH, Polliotti BM, Fisher SJ: Hypoxia alters early gestation human cytotrophoblast differentiation/invasion in vitro and models the placental defects that occur in preeclampsia. J Clin Invest 1996; 97:540-550.
5. Zhou Y, Damsky CH, Fisher SJ: Preeclampsia is associated with failure of human cytotrophoblasts to mimic a vascular adhesion phenotype:One cause of defective endovascular invasion in this syndrome? J Clin Invest 1997; 99:2152-2164.
6. Pijnenborg R, Luyten C, Vercruysse L, Van Assche FA: Attachment and differentiation in vitro of trophoblast from normal and preeclamptic human placentas. Am J Obstet Gynecol 1996; 175:30-36.
7. Gerritsen G, Huisjes HJ, Elema JD: Morphological changes of spiral arteries in the placental bed in relation to preeclampsia and fetal growth retardation. Br J Obstet Gynaecol 1981; 88:876-881.
8. Khong TY, De Wolf F, Robertson WB, Brosens I: Inadequate maternal vascular response to placentation in pregnancies complicated by preeclampsia and small-for-gestational-age infants. Br J Obstet Gynaecol 1981; 93:1049-1059.
9. Liaw L, Almeida M, Hart CE, Schwartz SM, Giachelli CM: Osteopontin promotes vascular cell adhesion and spreading and is chemotactic for smooth muscle cells in vitro. Circ Res 1994; 74:214-224.
10. Liaw L, Skinner MP, Raines EW, Ross R, Cheresh DA, Schwartz SM, Giachelli CM: The adhesive and migratory effects of osteopontin are mediated via distinct cell surface integrins: Role of alpha v beta 3 in smooth muscle cell migration to osteopontin in vitro. J Clin Invest 1995; 95:713-724.
11. Oldberg A, Franzen A, Heinegard D: Cloning and sequence analysis of rat bone sialoprotein (osteopontin) cDNA reveals an Arg-Gly-Asp cell binding sequence. Proc Natl Acad Sci USA 1986; 83:8819-8823.
12. Yue TL, McKenna PJ, Ohlstein EH, Farach-Carson MC, Butler WT, Johanson K, McDevitt P, Feuerstein GZ, Stadel JM: Osteopontin-stimulated vascular smooth muscle cell migration is mediated by beta 3 integrin. Exp Cell Res 1994; 214:459-464.
13. Brown LF, Berse B, Van de Water L, Papadopoulos-Sergiou A, Perruzzi CA, Manseau EJ, Dvorak HF, Senger DR: Expression and distribution of osteopontin in human tissues: Widespread association with luminal epithelial surfaces. Mol Biol Cell 1992; 3:1169-1180.
14. Daiter E, Omigbodun A, Wang S, Walinsky D, Strauss JF III, Hoyer JR, Coutifaris C: Cell differentiation and endogenous cyclic adenosine 3′,5′-monophosphate regulate osteopontin expression in human trophoblasts. Endocrinology 1996; 137:1785-1790.
15. Green RS, Lieb ME, Weintraub AS, Gacheru SN, Rosenfield CL, Shah S, Kagan HM, Taubman MB: Identification of lysyl oxidase and other PDGF-inducible genes in vascular smooth muscle cells by differential screening. Lab Invest 1995; 73:476-482.
16. Liaw L, Linder V, Schwartz SM, Chambers AF, Giachelli CM: Osteopontin and beta 3 integrin are coordinately expressed in regenerating endothelium in vivo and stimulate Arg-Gly-Asp-dependent endothelial migration in vitro. Circ Res 1995; 77:665-672.
17. Shanahan CM, Weissberg PL, Metacalfe JC: Isolation of gene markers of differentiated and proliferating vascular smooth muscle cells. Circ Res 1993; 73:193-204.
18. Weintraub AS, Giachelli CM, Krauss RS, Almeida M, Taubman MB: Autocrine secretion of osteopontin by vascular smooth muscle cells regulates their adhesion to collagen gels. Am J Pathol 1996; 149:259-272.
19. Chambers AF, Behrend EI, Wilson SM, Denhardt DT: Induction of expression of osteopontin in metastatic, ras-transformed NIH 3T3 cells. Anticancer Res 1993; 53:701-706.
20. Denhardt DT, Guo X: Osteopontin: A protein with diverse functions. FASEB J 1993; 7:1475-1482.
21. Weber GF, Ashkar S, Cantor H: Interaction between CD44 and osteopontin as a potential basis for metastasis formation. Proc Assoc Am Physicians 1997; 109:1-9.
22. Behrend EI, Craig AM, Wilson SM, Denhardt DT, Chambers AF: Reduced malignancy of ras-transformed NIH 3T3 cells expressing antisense osteopontin RNA. Cancer Res 1994; 54:832-837.
23. Brown LF, Papadopoulos-Sergiou A, Berse B, Manseau EJ, Tognazzi K, Perruzzi CA, Dvorak HF, Senger DR: Osteopontin expression and distribution in human carcinomas. Am J Pathol 1994; 145:610-623.
24. Feng B, Rollo EE, Denhardt DT: Osteopontin may facilitate metastasis by protecting cells from macrophage NO-mediated cytotoxicity: Evidence from cell lines down-regulated for OPN expression by a targeted ribozyme. Clin Exp Metastasis 1995; 13:453-462.
25. Chesley L: Diagnostic criteria for preeclampsia. Obstet Gynecol 1985; 65:423-425.
26. Lubchenco LO, Hansman C, Boyd E: Intrauterine growth in length and head circumference as estimated from live births at gestational ages from 26-42 weeks. Pediatrics 1996; 37:403-408.
27. Gorski JP, Griffin D, Dudley G, Stanford C, Thomas R, Huang C, Lai E, Karr B, Solursh M: Bone acidic glycoprotein-75 is a major synthetic product of osteoblastic cells and localized as 75- and/or 50-kDa forms in mineralized phases of bone and growth plate and in serum. J Biol Chem 1990; 265:14956-14963.
28. Young MF, Kerr JM, Termine JD, Wewer UM, Wang MG, McBride OW, Fisher LW: cDNA cloning, mRNA distribution and heterogeneity, chromosomal location, and RFLP analysis of human osteopontin. Genomics 1990; 7:491-502.
29. Librach CL, Werb Z, Fitzgerald ML, Chiu K, Corwin NM, Esteves RA, Grobelney D, Galardy R, Damsky CH, Fisher SJ: 92-kD type IV collagenase mediates invasion of human cytotrophoblasts. J Cell Biol 1991; 113:437-449.
30. Brooks PC, Clark RA, Cheresh DA: Requirement of vascular integrin alpha v beta 3 for angiogenesis. Science 1994; 264:569-571.
31. Damsky CH, Librach C, Lim KH, Fitzgerald ML, McMaster MT, Janatpour M, Zhou Y, Logan SK, Fisher SJ: Integrin switching regulates normal trophoblast invasion. Development 1994; 120:3657-3666.
32. Werb Z, Tremble P, Behrendsten O, Crowley E, Damsky CH: Signal transduction through the fibronectin receptor induces collagenase and stromelysin gene expression. J Cell Biol 1989; 109:877-889.
33. Burrows TD, King A, Smith SK, Loke YW: Human trophoblast adhesion to matrix proteins: inhibition and signal transduction. Human Reprod 1995; 10:2489-2400.
34. Fazleabas AT, Bell SC, Fleming S, Sun J, Lessey BA: Distribution of integrins and extracellular matrix proteins in the baboon endometrium during the menstrual cycle and early pregnancy. Biol Reprod 1997; 56:348-356.